Health Cor Management, L.P. Seagen Inc. Transaction History

Health Cor Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $6.18 Million - $8.23 Million	-45,720 Reduced 44.36%	57,340 $7.85 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $11.2 Million - $18.5 Million	103,060 New	103,060 $18.2 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $4.05 Million - $5.35 Million	-33,890 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $4.83 Million - $6.47 Million	33,890 New	33,890 $5.24 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.